BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18767093)

  • 21. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies.
    Krungkrai J; Krungkrai SR; Supuran CT
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5466-71. PubMed ID: 18805693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
    Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT
    J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
    Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1855-7. PubMed ID: 19269822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
    Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
    Bertucci A; Innocenti A; Zoccola D; Scozzafava A; Tambutté S; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):5054-8. PubMed ID: 19520577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?
    De Simone G; Scozzafava A; Supuran CT
    Chem Biol Drug Des; 2009 Sep; 74(3):317-21. PubMed ID: 19703035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition effects of selected thiophene-2-sulfonamides on lactoperoxidase.
    Köksal Z
    Drug Chem Toxicol; 2021 Jul; 44(4):359-364. PubMed ID: 31010344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.
    Lai C; Gum RJ; Daly M; Fry EH; Hutchins C; Abad-Zapatero C; von Geldern TW
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1807-10. PubMed ID: 16446092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study of interactions of carbonic anhydrase B with water and urea. I. Spin-diffusion parameters that determine individual and cooperative properties of molecules].
    Kutyshenko VP; Prokhorov DA; Khristoforov VS
    Biofizika; 2005; 50(4):641-7. PubMed ID: 16212054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.
    Oltulu O; Yaşar MM; Eroğlu E
    Eur J Med Chem; 2009 Sep; 44(9):3439-44. PubMed ID: 19303173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors.
    Neelamkavil SF; Boyle CD; Chackalamannil S; Greenlee WJ; Zhang L; Terracina G
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4563-5. PubMed ID: 19625185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties.
    Singer M; Lopez M; Bornaghi LF; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2273-6. PubMed ID: 19286378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
    Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273.
    Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
    J Med Chem; 2009 Jul; 52(13):4063-7. PubMed ID: 19438226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2alpha inhibitors.
    Chen L; Wang W; Lee KL; Shen MW; Murphy EA; Zhang W; Xu X; Tam S; Nickerson-Nutter C; Goodwin DG; Clark JD; McKew JC
    J Med Chem; 2009 Feb; 52(4):1156-71. PubMed ID: 19178292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
    Carta F; Pothen B; Maresca A; Tiwari M; Singh V; Supuran CT
    Chem Biol Drug Des; 2009 Aug; 74(2):196-202. PubMed ID: 19549076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies.
    Wang X; Lin J; Chen Y; Zhong W; Zhao G; Liu H; Li S; Wang L; Li S
    Bioorg Med Chem; 2009 Mar; 17(5):1898-904. PubMed ID: 19223187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
    Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
    Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.